Perlmutter Cancer Center at NYU Langone Hospital-Long Island — New York, New York

Perlmutter Cancer Center at NYU Langone Hospital-Long Island is a clinical research site located in New York, New York, United States 11501.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Perlmutter Cancer Center at NYU Langone Hospital-Long Island has participated in 1 clinical trials.

Therapeutic areas: HPV-Related Squamous Cell Carcinoma.

Sponsors: Hookipa Biotech GmbH.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Perlmutter Cancer Center at NYU Langone Hospital-Long Island?

Perlmutter Cancer Center at NYU Langone Hospital-Long Island has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Perlmutter Cancer Center at NYU Langone Hospital-Long Island conducted?

Perlmutter Cancer Center at NYU Langone Hospital-Long Island has 1 clinical trials on record. Their work covers HPV-Related Squamous Cell Carcinoma.

Is Perlmutter Cancer Center at NYU Langone Hospital-Long Island accredited by Crixeo Health?

Perlmutter Cancer Center at NYU Langone Hospital-Long Island has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Perlmutter Cancer Center at NYU Langone Hospital-Long Island?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.